Kaneko MK - Search Results

1

Anti‑HER3 monoclonal antibody exerts antitumor activity in a mouse model of colorectal adenocarcinoma.

Asano T, Ohishi T, Takei J, Nakamura T, Nanamiya R, Hosono H, Tanaka T, Sano M, Harada H, Kawada M, Kaneko MK, Kato Y. Asano T, et al. Among authors: kaneko mk. Oncol Rep. 2021 Aug;46(2):173. doi: 10.3892/or.2021.8124. Epub 2021 Jun 29. Oncol Rep. 2021. PMID: 34184091 Free PMC article.

2

Molecular characterization of a human monoclonal antibody to B antigen in ABO blood type.

Kaneko M, Kato Y, Horiuchi H, Osawa M. Kaneko M, et al. Immunol Lett. 2003 Mar 3;86(1):45-51. doi: 10.1016/s0165-2478(02)00294-8. Immunol Lett. 2003. PMID: 12600744

3

Molecular identification of Aggrus/T1alpha as a platelet aggregation-inducing factor expressed in colorectal tumors.

Kato Y, Fujita N, Kunita A, Sato S, Kaneko M, Osawa M, Tsuruo T. Kato Y, et al. J Biol Chem. 2003 Dec 19;278(51):51599-605. doi: 10.1074/jbc.M309935200. Epub 2003 Oct 1. J Biol Chem. 2003. PMID: 14522983 Free article.

4

Functional sialylated O-glycan to platelet aggregation on Aggrus (T1alpha/Podoplanin) molecules expressed in Chinese hamster ovary cells.

Kaneko M, Kato Y, Kunita A, Fujita N, Tsuruo T, Osawa M. Kaneko M, et al. J Biol Chem. 2004 Sep 10;279(37):38838-43. doi: 10.1074/jbc.M407210200. Epub 2004 Jul 1. J Biol Chem. 2004. PMID: 15231832 Free article.

5

Aggrus: a diagnostic marker that distinguishes seminoma from embryonal carcinoma in testicular germ cell tumors.

Kato Y, Sasagawa I, Kaneko M, Osawa M, Fujita N, Tsuruo T. Kato Y, et al. Oncogene. 2004 Nov 4;23(52):8552-6. doi: 10.1038/sj.onc.1207869. Oncogene. 2004. PMID: 15361850

6

Enhanced expression of Aggrus (T1alpha/podoplanin), a platelet-aggregation-inducing factor in lung squamous cell carcinoma.

Kato Y, Kaneko M, Sata M, Fujita N, Tsuruo T, Osawa M. Kato Y, et al. Tumour Biol. 2005 Jul-Aug;26(4):195-200. doi: 10.1159/000086952. Epub 2005 Jul 7. Tumour Biol. 2005. PMID: 16006773

7

Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression.

Mishima K, Kato Y, Kaneko MK, Nishikawa R, Hirose T, Matsutani M. Mishima K, et al. Among authors: kaneko mk. Acta Neuropathol. 2006 May;111(5):483-8. doi: 10.1007/s00401-006-0063-y. Epub 2006 Apr 5. Acta Neuropathol. 2006. PMID: 16596424

8

Conservation of a platelet activating domain of Aggrus/podoplanin as a platelet aggregation-inducing factor.

Kaneko MK, Kato Y, Kitano T, Osawa M. Kaneko MK, et al. Gene. 2006 Aug 15;378:52-7. doi: 10.1016/j.gene.2006.04.023. Epub 2006 May 11. Gene. 2006. PMID: 16766141

9

Induction of podoplanin by transforming growth factor-beta in human fibrosarcoma.

Suzuki H, Kato Y, Kaneko MK, Okita Y, Narimatsu H, Kato M. Suzuki H, et al. Among authors: kaneko mk. FEBS Lett. 2008 Jan 23;582(2):341-5. doi: 10.1016/j.febslet.2007.12.028. Epub 2007 Dec 26. FEBS Lett. 2008. PMID: 18158922 Free article.

10

Expression of highly sulfated keratan sulfate synthesized in human glioblastoma cells.

Hayatsu N, Ogasawara S, Kaneko MK, Kato Y, Narimatsu H. Hayatsu N, et al. Among authors: kaneko mk. Biochem Biophys Res Commun. 2008 Apr 4;368(2):217-22. doi: 10.1016/j.bbrc.2008.01.058. Epub 2008 Jan 22. Biochem Biophys Res Commun. 2008. PMID: 18211804

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

329 results

Search Page

Filters